Godrej Agrovet Limited (GAVL) announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, at its Board of Directors meeting held on August 5, 2026. The company reported double-digit consolidated sales growth on a year-on-year basis, though profitability came under pressure due to cost headwinds across select business segments.

Q1 FY27 Financial Performance

Consolidated sales for Q1 FY27 stood at ₹2,852 crore, compared to ₹2,603 crore in Q1 FY26, reflecting healthy top-line growth. However, profit before tax (excluding share of profit from joint ventures and non-recurring items) declined to ₹172 crore from ₹188 crore in the corresponding quarter of the previous year, indicating margin pressure during the period.

The following table summarises the key consolidated financial metrics for Q1 FY27 on a year-on-year basis:

* Profit before tax excludes share of profit from Joint Venture

Managing Director's Comments

Commenting on the performance, Mr. Sunil Kataria, Chief Executive Officer & Managing Director, Godrej Agrovet Limited, noted that the company delivered a resilient performance in Q1 FY27, with consolidated sales reporting double-digit growth despite a challenging environment marked by delayed monsoon conditions and geopolitical tensions that led to inflationary pressures. He highlighted that while profitability was impacted by temporary cost headwinds in select businesses, the company remains confident of navigating these challenges through operational excellence and focused cost management. Kataria also pointed to the significant improvement in net working capital over the past two years as a reflection of disciplined focus on capital allocation, cash generation, and value creation.

Segment-Wise Business Highlights

The quarter saw varied performance across Godrej Agrovet's diversified business segments. The following table provides an overview of key segment developments:

Animal Nutrition and Oil Palm

Animal Nutrition delivered a standout quarter, with cattle feed volumes growing approximately 15% year-on-year, reinforcing the business's leadership position. Underlying segment results improved by approximately 36% YoY, reflecting benefits from strategic commodity sourcing, operating leverage, and cost discipline. The Oil Palm business also performed strongly, with improved realizations and enhanced oil extraction efficiency driving growth in both revenue and profitability. Fresh Fruit Bunch (FFB) volumes remained broadly flat against a high comparable base in Q1 FY26, which had benefited from an early monsoon onset.

Crop Care, Astec LifeSciences, and Dairy

The Crop Care business faced headwinds from a significantly delayed monsoon and slower kharif sowings following one of the driest June months in over a decade, resulting in lower volumes of the company's in-house cotton herbicide and consequent margin contraction. However, the strategic scale-up of Ashitaka (Maize Herbicide) and Takai (Paddy insecticide) helped partially offset the impact. Astec LifeSciences sustained its recovery momentum, achieving EBITDA break-even and substantially improving EBITDA over Q1 FY26, driven by margin expansion across both Enterprise and CDMO categories. The Dairy business delivered healthy revenue growth backed by strong volume growth in value-added products, with value-added product salience improving from 42% in Q1 FY26 to 49% in Q1 FY27, though EBITDA was impacted by elevated milk procurement prices and war-related input inflation.

About Godrej Agrovet Limited

Godrej Agrovet Limited is a diversified, Research & Development focused agri-business company dedicated to improving the productivity of Indian farmers by innovating products and services that sustainably increase crop and livestock yields. GAVL holds leading market positions across Animal Nutrition, Crop Care, Oil Palm, Dairy, and Poultry and Processed Foods, with a pan-India presence and annual sales of over a million tons of high-quality animal feed. The company also operates through subsidiaries Astec Life Sciences Limited, Creamline Dairy Products Limited, and Godrej Tyson Foods Limited, and maintains a joint venture with the ACI group of Bangladesh for the animal feed business.

Godrej Agrovet reported Q1FY27 results on August 5, 2026, highlighting a strategic pivot toward value creation amid mixed segmental performance. The Board of Directors approved the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. While the company faced transient cost pressures and weather-related headwinds, it delivered resilient topline growth in key segments. Management emphasized a structural reset to streamline the complex portfolio, shift from a commodity mindset to customer-facing capabilities, and focus capital allocation on high-return businesses.

The Animal Nutrition business in India demonstrated robust growth, with cattle feed volumes rising approximately 15% year-on-year. This volume expansion, driven by strong demand and improved realizations, contributed to a material improvement in margin performance. Underlying segment results improved by roughly 36% year-on-year, reflecting benefits from strategic commodity sourcing, operating leverage, and cost discipline. In Bangladesh, the joint venture ACI Godrej Agrovet also returned to a growth trajectory, with profit before tax increasing by 12% year-on-year due to operational leverage and volume growth.

Segment Performance Highlights

The Oil Palm Business saw a 43 basis points growth in Oil Extraction Ratio (OER) and a 14% increase in EBIT. Fresh fruit bunch volumes remained broadly flat compared to a high-comparable base in Q1FY26. Excluding trading revenues of ₹ 29 crore in Q1FY27 (compared to ₹ 41 crore in Q1FY26), segment revenue was driven by improved realizations and higher sales volumes.

Conversely, the Crop Care Business experienced de-growth in revenue, estimated at approximately 17%, primarily due to lower volumes of in-house cotton herbicides. Demand remained muted amid a significantly delayed monsoon and slower kharif sowings following one of the driest Junes in over a decade. However, new launches such as Ashitaka (Maize Herbicide) and Takai (Paddy insecticide) gained market traction, with Ashitaka volumes scaling threefold to 30 kL in Q1FY27.

Strategic Reset and Portfolio Streamlining

Management outlined a plan to build multiple pillars of growth within each business while reducing exposure to unprofitable or sub-scale segments. The company identified specific businesses for strategic review, including Shrimp Feed, and plans to close live bird trading. Capital expenditure is expected to continue at ₹ 300 – 350 crore per year, funded through internal accruals, with a majority allocated to high-margin, high ROCE businesses. The company also emphasized sharp focus on managing Net Working Capital to improve Return on Capital Employed (ROCE).

What the Numbers Show

A notable divergence exists between the operational performance of ACI Godrej Agrovet and its bottom-line impact. While Profit Before Tax increased by 12% year-on-year due to operational leverage, Profit After Tax declined. This decline was primarily driven by a higher effective tax rate following a change in the applicable tax rate from 15% to 27.5% effective July 1, 2025. This indicates that the dip in net profitability was regulatory rather than operational, preserving the integrity of the underlying business recovery.

Godrej Foods Ltd. maintained stable revenues despite a deliberate reduction in live bird volumes, supported by a 22% volume growth in the Yummiez brand. Approximately 20% of GFL’s B2C revenue in Q1FY27 came from new product developments across frozen chicken, momos, and nuggets. Creamline Dairy saw revenue grow by 11%, driven by strong volume growth in value-added products, although EBITDA was impacted by elevated milk procurement prices and inflationary pressures.